IBDEI02X ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,824,0)
 ;;=L97.224^^3^32^74
 ;;^UTILITY(U,$J,358.3,824,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,824,1,3,0)
 ;;=3^Non-prs chr ulcer of left calf w necrosis of bone
 ;;^UTILITY(U,$J,358.3,824,1,4,0)
 ;;=4^L97.224
 ;;^UTILITY(U,$J,358.3,824,2)
 ;;=^5009508
 ;;^UTILITY(U,$J,358.3,825,0)
 ;;=L97.324^^3^32^68
 ;;^UTILITY(U,$J,358.3,825,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,825,1,3,0)
 ;;=3^Non-prs chr ulcer of left ankle w necrosis of bone
 ;;^UTILITY(U,$J,358.3,825,1,4,0)
 ;;=4^L97.324
 ;;^UTILITY(U,$J,358.3,825,2)
 ;;=^5009523
 ;;^UTILITY(U,$J,358.3,826,0)
 ;;=L97.329^^3^32^70
 ;;^UTILITY(U,$J,358.3,826,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,826,1,3,0)
 ;;=3^Non-prs chr ulcer of left ankle with unsp severity
 ;;^UTILITY(U,$J,358.3,826,1,4,0)
 ;;=4^L97.329
 ;;^UTILITY(U,$J,358.3,826,2)
 ;;=^5009524
 ;;^UTILITY(U,$J,358.3,827,0)
 ;;=L97.323^^3^32^69
 ;;^UTILITY(U,$J,358.3,827,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,827,1,3,0)
 ;;=3^Non-prs chr ulcer of left ankle w necrosis of muscle
 ;;^UTILITY(U,$J,358.3,827,1,4,0)
 ;;=4^L97.323
 ;;^UTILITY(U,$J,358.3,827,2)
 ;;=^5009522
 ;;^UTILITY(U,$J,358.3,828,0)
 ;;=L97.322^^3^32^67
 ;;^UTILITY(U,$J,358.3,828,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,828,1,3,0)
 ;;=3^Non-prs chr ulcer of left ankle w fat layer exposed
 ;;^UTILITY(U,$J,358.3,828,1,4,0)
 ;;=4^L97.322
 ;;^UTILITY(U,$J,358.3,828,2)
 ;;=^5009521
 ;;^UTILITY(U,$J,358.3,829,0)
 ;;=L97.319^^3^32^90
 ;;^UTILITY(U,$J,358.3,829,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,829,1,3,0)
 ;;=3^Non-prs chr ulcer of right ankle with unsp severity
 ;;^UTILITY(U,$J,358.3,829,1,4,0)
 ;;=4^L97.319
 ;;^UTILITY(U,$J,358.3,829,2)
 ;;=^5009519
 ;;^UTILITY(U,$J,358.3,830,0)
 ;;=L97.321^^3^32^66
 ;;^UTILITY(U,$J,358.3,830,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,830,1,3,0)
 ;;=3^Non-prs chr ulcer of left ankle limited to brkdwn skin
 ;;^UTILITY(U,$J,358.3,830,1,4,0)
 ;;=4^L97.321
 ;;^UTILITY(U,$J,358.3,830,2)
 ;;=^5009520
 ;;^UTILITY(U,$J,358.3,831,0)
 ;;=L97.314^^3^32^88
 ;;^UTILITY(U,$J,358.3,831,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,831,1,3,0)
 ;;=3^Non-prs chr ulcer of right ankle w necrosis of bone
 ;;^UTILITY(U,$J,358.3,831,1,4,0)
 ;;=4^L97.314
 ;;^UTILITY(U,$J,358.3,831,2)
 ;;=^5009518
 ;;^UTILITY(U,$J,358.3,832,0)
 ;;=L97.313^^3^32^89
 ;;^UTILITY(U,$J,358.3,832,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,832,1,3,0)
 ;;=3^Non-prs chr ulcer of right ankle w necrosis of muscle
 ;;^UTILITY(U,$J,358.3,832,1,4,0)
 ;;=4^L97.313
 ;;^UTILITY(U,$J,358.3,832,2)
 ;;=^5009517
 ;;^UTILITY(U,$J,358.3,833,0)
 ;;=L97.311^^3^32^86
 ;;^UTILITY(U,$J,358.3,833,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,833,1,3,0)
 ;;=3^Non-prs chr ulcer of right ankle limited to brkdwn skin
 ;;^UTILITY(U,$J,358.3,833,1,4,0)
 ;;=4^L97.311
 ;;^UTILITY(U,$J,358.3,833,2)
 ;;=^5009515
 ;;^UTILITY(U,$J,358.3,834,0)
 ;;=L97.312^^3^32^87
 ;;^UTILITY(U,$J,358.3,834,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,834,1,3,0)
 ;;=3^Non-prs chr ulcer of right ankle w fat layer exposed
 ;;^UTILITY(U,$J,358.3,834,1,4,0)
 ;;=4^L97.312
 ;;^UTILITY(U,$J,358.3,834,2)
 ;;=^5009516
 ;;^UTILITY(U,$J,358.3,835,0)
 ;;=L97.411^^3^32^96
 ;;^UTILITY(U,$J,358.3,835,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,835,1,3,0)
 ;;=3^Non-prs chr ulcer of right heel and midft lmt to brkdwn skin
 ;;^UTILITY(U,$J,358.3,835,1,4,0)
 ;;=4^L97.411
 ;;^UTILITY(U,$J,358.3,835,2)
 ;;=^5009530
 ;;^UTILITY(U,$J,358.3,836,0)
 ;;=L97.413^^3^32^97
 ;;^UTILITY(U,$J,358.3,836,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,836,1,3,0)
 ;;=3^Non-prs chr ulcer of right heel and midfoot w necros muscle
